Opiant Pharmaceuticals to Report Third Quarter 2022 Financial Results and Host Conference Call and Webcast on November 14, 2022

Rhea-AI Summary

Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) will report its third-quarter financial results on November 14, 2022, after market close. A conference call will follow at 4:30 PM ET, accessible via U.S. and international lines. Opiant specializes in developing medicines for addiction and overdose treatment, including the NARCAN® Nasal Spray. The company aims to build a robust portfolio in this critical healthcare area, emphasizing its commitment to combating substance-related emergencies.

SANTA MONICA, Calif., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant” or “Company”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines to treat addictions and drug overdose, today announced it will report its financial results for the third quarter ended September 30, 2022, after the financial markets close on Monday, November 14, 2022.  

The Company’s management team is scheduled to host a conference call and webcast at 4:30 p.m. ET on Monday, November 14, 2022. To access the call, please dial 1-877-407-0792 in the U.S. or 1-201-689-8263 outside the U.S. and provide the conference ID number: 13732765. To access the live webcast, please visit https://viavid.webcasts.com/starthere.jsp?ei=1569474&tp_key=bb26315c9c. Following the live webcast, an archived version of the call will be available on the website.

Monday November 14 @ 4:30 pm ET
Domestic:	1-877-407-0792
International:	1-201-689-8263
Conference ID:	13732765
Webcast:	https://viavid.webcasts.com/starthere.jsp?ei=1569474&tp_key=bb26315c9c

About Opiant Pharmaceuticals, Inc.
Opiant Pharmaceuticals, Inc., the company that developed NARCAN^® Nasal Spray, is building a leading franchise of new medicines to combat addictions and drug overdose. For more information visit: www.opiant.com.

For Media and Investor Inquiries:
Ben Atkins, Opiant
(310) 598-5410
batkins@opiant.com

FAQ

When will Opiant Pharmaceuticals release its Q3 2022 financial results?

Opiant Pharmaceuticals will release its Q3 2022 financial results on November 14, 2022, after market close.

What time is the Opiant Pharmaceuticals conference call scheduled?

The Opiant Pharmaceuticals conference call is scheduled for 4:30 PM ET on November 14, 2022.

How can I access the Opiant Pharmaceuticals Q3 financial results conference call?

You can access the conference call by dialing 1-877-407-0792 (U.S.) or 1-201-689-8263 (international) and using conference ID 13732765.

Where can I find the webcast for the Opiant Pharmaceuticals financial results?

The webcast for the Opiant Pharmaceuticals financial results can be found at https://viavid.webcasts.com/starthere.jsp?ei=1569474&tp_key=bb26315c9c.